Clinical Trials Logo

Clinical Trial Summary

the investigators hypothesize that patients do not understand these therapies, and that they are poorly undertaken. In some cases, the anesthesiologist does not understand correctly the indication of the treatment due to lack of information and therefore does not know how to adapt it to the medical situation.


Clinical Trial Description

the investigators hypothesize that patients do not understand these therapies, and that they are poorly undertaken. In some cases, the anesthesiologist does not understand correctly the indication of the treatment due to lack of information and therefore does not know how to adapt it to the medical situation.

the investigators want to investigate these transitions: how were they understood by patients, how were they performed, and how does this affect surgery, postoperative morbidity and mortality?

Anticoagulation for prevention of thromboembolic events will not be studied in this study.

The anesthesia team will not be particularly trained in anticoagulants and antiplatelets management to be close to actual care. In the Hospital the investigators have a guide written in 2013 in order to describe all the cases possible. The "control/ goal group" will be the patients who have undertaken strictly the protocol described for their cases in the guide. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03871283
Study type Observational
Source Erasme University Hospital
Contact
Status Completed
Phase
Start date January 1, 2019
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT04517461 - Coagulation and Vitamin K in Head and Neck Microvascular Free Flap Surgery
Terminated NCT03296033 - Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin Phase 4
Recruiting NCT05123326 - Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome
Completed NCT04074980 - Evaluation of the Accuracy of INR Results From Patients Taking Phenprocoumon as Anticoagulant When Measured Using the Lumiradx INR Test N/A
Completed NCT04505475 - Oral Surgery in Patients Taking Direct Oral Anticoagulants
Not yet recruiting NCT05997914 - Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation N/A
Recruiting NCT04329390 - MAC Project, Monitoring of AntiCoagulant Therapies (MAC)
Completed NCT03112525 - DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic
Recruiting NCT03760874 - Atrial Fibrillation Research Database
Recruiting NCT04046029 - Bivalirudin in Elderly Patients Undergoing Elective Percutaneous Coronary Intervention. Phase 4
Completed NCT04444700 - A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care as a Rapid Response to (SARS-CoV-2) COVID-19 Pandemic Phase 3
Terminated NCT03566303 - Rivaroxaban vs Warfarin in Patients With Metallic Prosthesis Phase 2/Phase 3
Not yet recruiting NCT04128254 - A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE) Phase 4
Recruiting NCT05946850 - Caudal Analgesia & Anticoagulated Patient
Recruiting NCT05946863 - Caudal Block & Hip Fracture Surgery in Anticoagulated Patient
Recruiting NCT05545475 - Safety of Anticoagulant Therapy After Tissue Glue for Gastric Varices
Completed NCT06269302 - Comparison of the Effect of Warfarin and Direct Oral Anticoagulants
Recruiting NCT04676880 - Left Atrial Appendage Occlusion for AF Patients Unable to Use Oral Anticoagulation Therapy N/A
Completed NCT05224388 - Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular Weight Heparin in Critical Ill Patients Versus Critical Ill COVID-19 Patients Using Anti-Xa Levels.
Completed NCT03232398 - Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus Phase 3